White Spot LesionNCT07319884
The Role of Fluoride Varnish Application in Preventing White Spot Lesions During Clear Aligner Treatment: A Controlled Split-Mouth Study
A study testing White spot lesion with fluoride varnish application and White spot lesion without fluoride varnish application in people with White Spot Lesion, run by Mansoura University at 1 site in Egypt.
Trial summary
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy Design Details: Each participant will have one side of the mouth assigned to the fluoride varnish intervention, while the contralateral side will serve as the control… Read more about this study
- Who is it for?
- Ages 16 to 24 yearsHealthy volunteers can take part
- Conditions the study is for
- White Spot Lesion
- What is being tested?
- White spot lesion with fluoride varnish application and White spot lesion without fluoride varnish application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 25 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Jun 2025to 1 Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 24 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- patients aged 16-24 years.
- Good general and oral health.
- Mild dental crowding per arch (≤ 4 mm).
- Eruption of all permanent dention excluding third molar
Who cannot join
- Allergy to fluoride material
- Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders).
- Patients with Cleft lip and palate
- Previous orthodontic treatment
- dental fluorosis.
- hypocalcified teeth or visible demineralization
Trial locations and contacts
1 site in 1 country.
About this study
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy
Design Details: Each participant will have one side of the mouth assigned to the fluoride varnish intervention, while the contralateral side will serve as the control without fluoride varnish.
Outcomes:
Primary outcome: Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Secondary Outcome:
Periodontal Ligament (PDL) Health using pocket Depth Index (PDI) Gingival Bleeding and Inflammation using bleeding on Probing Index (BOP)
Read the detailed description
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy in comparison to a split mouth-controlled group
Sample size calculation:
The sample size was calculated using G* power software (version3.1.9.7) and was designed to have a power of 85% assuming a type I statistical error of 5% and a one tailed statistical test with an effect size f= 0.7730012 based on the study of Najafi et al. The means and standard deviation of the DIAGNOdent score of the varnish and control groups after six months were 1.23 ±0.45 and 1.78±0.90. The calculated sample size will be 25 patients. The sample size will be increased to include 30 patients to avoid any drop out.
Material and methods:
- Initial Oral Scan:
- A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner
- Aligner Fabrication:
- aligners will be fabricated using thermoforming techniques.
- A clear aligner sheet (e.g.Duran) is heated and vacuum or pressure-formed over the 3D-printed model, then trimming followed by finishing and polishing
- Interventions
Intervention Group (Test Side):
- Application of a preventive fluoride varnish (Charm varnish) on the indicated side of the mouth before clear aligner fitting.
Control Group (Control Side):
- Without application of fluoride varnish 4. Aligner Placement:
- The aligners will be fitted, and patients will wear them continuously, except during eating and brushing.
Outcome Measures:
Primary Outcome:
- Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Secondary Outcome:
- Periodontal Ligament (PDL) Health using:
- Pocket Depth Index (PDI)
- Gingival Bleeding and Inflammation using:
- Bleeding on Probing Index (BOP)
Randomization and Application Site
To minimize bias, the side of the maxillary arch (right or left upper side) for fluoride varnish application was randomly assigned for each of the patients using a computer-generated randomization sequence
Inclusion and Exclusion Criteria Eligible participants were patients aged 16-24 years, representing the typical demographic for clear aligner therapy and ensuring biological consistency in terms of tooth development and orthodontic response. All participants were required to be in good general and oral health to minimize confounding factors related to systemic or oral disease, to present with mild dental crowding in each arch to standardize treatment complexity, and to have full eruption of all permanent teeth excluding third molars to allow consistent varnish application and assessment. Patients were excluded if they had a known allergy or hypersensitivity to fluoride-containing materials, systemic conditions that could affect tooth movement (such as diabetes or bone metabolism disorders), cleft lip and/or palate or other craniofacial anomalies, a history of previous orthodontic treatment, or clinical evidence of dental fluorosis, as these factors could alter enamel characteristics, orthodontic response, or lesion assessment and thereby introduce bias into the study outcomes.
Duration of the study:
- This study is suggested to be finished in 18 months
- Conditions
- White Spot Lesion
- Being tested
- White spot lesion with fluoride varnish application, White spot lesion without fluoride varnish application
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
White spot lesion with fluoride varnish applicationOther
Application of fluoride varnish at the cervical third of labial surface or around the attachment if present
White spot lesion without fluoride varnish applicationOther
No fluoride varnish application at the cervical third of the labial surface or around the attachment if present
| Study group | Role | What they receive |
|---|---|---|
| White spot lesion with fluoride varnish application during clear Aligner therapy | Experimental | Intervention Group (Test Side):
• Application of a preventive fluoride varnish on the indicated side of the mouth before clear aligner fitting. Receives: Other: White spot lesion with fluoride varnish application |
| White spot lesion without fluoride varnish application during clear Aligner therapy | Active comparator | Control Group (Control Side): No application of fluoride varnish. Receives: Other: White spot lesion without fluoride varnish application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence and Severity of White Spot Lesions
Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Measured: Six months
Secondary outcomes (2)
Periodontal Ligament (PDL) Health
Health using pocket Depth Index (PDI)
Measured: Six moths
Gingival Bleeding and Inflammation
using bleeding on Probing Index (BOP)
Measured: Six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jan 2026
- Study start25 Jun 2025
- Primary completion25 Jan 2027 (estimated)
- Study completion1 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for White Spot LesionStudies of the same condition, open and under way.
- More trials run by Mansoura UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jalal Alshami, Mansoura University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07319884
- Sponsor's protocol ID
- Mansoura-university
- Status last verified
- Dec 2025
- First submitted
- 20 Dec 2025
- Last updated
- 6 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Role of Fluoride Varnish Application in Preventing White Spot Lesions During Clear Aligner Treatment: A Controlled Split-Mouth Study
- ClinicalTrials.gov ID
- NCT07319884
- Acronym / sponsor ID
- Mansoura-university
- Conditions
- White Spot Lesion
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 25 participants (actual)
- Lead sponsor
- Mansoura UniversityUniversity, hospital or other
- Study start
- 25 Jun 2025 (actual)
- Primary completion
- 25 Jan 2027 (estimated)
- Study completion
- 1 Feb 2027 (estimated)
- First posted
- 6 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy
Design Details: Each participant will have one side of the mouth assigned to the fluoride varnish intervention, while the contralateral side will serve as the control without fluoride varnish.
Outcomes:
Primary outcome: Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Secondary Outcome:
Periodontal Ligament (PDL) Health using pocket Depth Index (PDI) Gingival Bleeding and Inflammation using bleeding on Probing Index (BOP)
Detailed description
aim of study: is to compare the effect of the fluoride varnish application on the prevention of white spot lesions (WSLs) during clear aligner therapy in comparison to a split mouth-controlled group
Sample size calculation:
The sample size was calculated using G* power software (version3.1.9.7) and was designed to have a power of 85% assuming a type I statistical error of 5% and a one tailed statistical test with an effect size f= 0.7730012 based on the study of Najafi et al. The means and standard deviation of the DIAGNOdent score of the varnish and control groups after six months were 1.23 ±0.45 and 1.78±0.90. The calculated sample size will be 25 patients. The sample size will be increased to include 30 patients to avoid any drop out.
Material and methods:
- Initial Oral Scan:
- A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner
- Aligner Fabrication:
- aligners will be fabricated using thermoforming techniques.
- A clear aligner sheet (e.g.Duran) is heated and vacuum or pressure-formed over the 3D-printed model, then trimming followed by finishing and polishing
- Interventions
Intervention Group (Test Side):
- Application of a preventive fluoride varnish (Charm varnish) on the indicated side of the mouth before clear aligner fitting.
Control Group (Control Side):
- Without application of fluoride varnish 4. Aligner Placement:
- The aligners will be fitted, and patients will wear them continuously, except during eating and brushing.
Outcome Measures:
Primary Outcome:
- Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
Secondary Outcome:
- Periodontal Ligament (PDL) Health using:
- Pocket Depth Index (PDI)
- Gingival Bleeding and Inflammation using:
- Bleeding on Probing Index (BOP)
Randomization and Application Site
To minimize bias, the side of the maxillary arch (right or left upper side) for fluoride varnish application was randomly assigned for each of the patients using a computer-generated randomization sequence
Inclusion and Exclusion Criteria Eligible participants were patients aged 16-24 years, representing the typical demographic for clear aligner therapy and ensuring biological consistency in terms of tooth development and orthodontic response. All participants were required to be in good general and oral health to minimize confounding factors related to systemic or oral disease, to present with mild dental crowding in each arch to standardize treatment complexity, and to have full eruption of all permanent teeth excluding third molars to allow consistent varnish application and assessment. Patients were excluded if they had a known allergy or hypersensitivity to fluoride-containing materials, systemic conditions that could affect tooth movement (such as diabetes or bone metabolism disorders), cleft lip and/or palate or other craniofacial anomalies, a history of previous orthodontic treatment, or clinical evidence of dental fluorosis, as these factors could alter enamel characteristics, orthodontic response, or lesion assessment and thereby introduce bias into the study outcomes.
Duration of the study:
- This study is suggested to be finished in 18 months
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| White spot lesion with fluoride varnish application during clear Aligner therapy | Experimental | Other: White spot lesion with fluoride varnish applicationIntervention Group (Test Side): • Application of a preventive fluoride varnish on the indicated side of the mouth before clear aligner fitting. |
| White spot lesion without fluoride varnish application during clear Aligner therapy | Active comparator | Other: White spot lesion without fluoride varnish applicationControl Group (Control Side): No application of fluoride varnish. |
Who may qualify
- Ages
- 16 to 24 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- patients aged 16-24 years.
- Good general and oral health.
- Mild dental crowding per arch (≤ 4 mm).
- Eruption of all permanent dention excluding third molar
Key exclusion criteria (6 listed)
- Allergy to fluoride material
- Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders).
- Patients with Cleft lip and palate
- Previous orthodontic treatment
- dental fluorosis.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| White spot lesion with fluoride varnish applicationApplication of fluoride varnish at the cervical third of labial surface or around the attachment if present | Other | White spot lesion with fluoride varnish application during clear Aligner therapy |
| White spot lesion without fluoride varnish applicationNo fluoride varnish application at the cervical third of the labial surface or around the attachment if present | Other | White spot lesion without fluoride varnish application during clear Aligner therapy |
Primary outcome
Incidence and Severity of White Spot Lesions
Time frame: Six months
Incidence and Severity of White Spot Lesions Measured before and after six months using Laser fluorescence (DIAGNOdent)
2 secondary outcomes
Periodontal Ligament (PDL) Health
Time frame: Six moths
Gingival Bleeding and Inflammation
Time frame: Six months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jan 2026.
Related trials for White Spot Lesion
Active, not recruiting
A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
Bracket Bonding, Orthodontic Treatment
Not yet recruitingObservational study
Artificial Intelligence Versus Clinical Examination in White Spot Lesions Detection, Identification, And Scoring
White Spot Lesion of Tooth
Recruiting
EFFICACY OF BIOMIN FLUORIDE VERSUS SODIUM FLUORIDE VARNISHES, WITH AND WITHOUT DIODE LASER ON WHITE SPOT LESIONS REMINERALIZATION IN PRIMARY TEETH.
White Spot Lesions [Initial Caries] on Smooth Surface of Tooth
Not yet recruiting
S-PRG Filler for Preventing White Spot Lesions During Orthodontic Treatment
White Spot Lesion of Tooth, Orthodontic Treatment
Recruiting
Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions
White Spot Lesions [Initial Caries] on Smooth Surface of Tooth
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing White spot lesion with fluoride varnish application and White spot lesion without fluoride varnish application in people with White Spot Lesion, run by Mansoura University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence and Severity of White Spot Lesions (time frame: Six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.